ClinicalTrials.Veeva

Menu

Transplantoux Health Evaluation Study (THES)

U

Universitaire Ziekenhuizen KU Leuven

Status

Enrolling

Conditions

Quality of Life

Treatments

Other: Home-based indiviualized exercise training program
Other: Supervised group training sessions
Other: Climb of the Mont Ventoux

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The primary aim is to evaluate the short- and long-term effect of the 'Transplantoux' exercise training intervention in solid organ transplant recipients with matched control sample of transplant recipients in view of selected Patient Reported Outcomes (PRO), i.e. health-related quality-of-life (HRQOL), psychosocial and behavioral variables, using a quasi-experimental design.

Full description

During the last decades advances in solid organ transplantation, like e.g. organ preservation, surgical techniques and immunosuppressive treatment have contributed to improvements in postoperative survival. Thereby, solid organ transplantation (Tx) has moved from experimental treatment towards a clinical reality and a life-saving surgery, offering most patients a good long-term survival. However, further improvement in long-term survival remains a major challenge.

It is increasingly recognized that non-pharmacological interventions hold the potential to improve long-term outcomes in transplantation as evidence shows that health behavior has been independently associated with transplant outcome (e.g. physical activity, non-smoking, medication adherence). Furthermore, exercise training interventions show positive outcome in a number of populations and limited research in transplantation shows positive outcomes in view of exercise capacity, muscle strength, cardiopulmonary variables and body composition. However, there is a lack of research that evaluates exercise training interventions in view of patient reported outcomes (PROs) in transplant recipients.

In the University Hospitals of Leuven (Belgium) a project named 'Transplantoux' has been launched to enhance physical activity and exercise capacity in transplant recipients. Transplant recipients participate in the 'Transplantoux' exercise training intervention for 6-months with the ultimate goal to cycle or hike up the Mont Ventoux (France) (distance: 25.9 km, mean slope: 4.4%). Extending on a previous safety feasibility study in which we demonstrated that selected Transplant recipients can safely participate in an intense exercise program and that exercise capacity was significantly improved after training. The primary aim of the current study is to evaluate the short- and long-term effect of the 'Transplantoux' intervention in view of selected Patient Reported Outcomes (PROs), i.e. perceived health-related quality-of-life, depressive symptomatology, stress and well-being, physical activity, social contacts and social support, and barriers and motivators to exercise.

The Transplantoux Health Evaluation Study (THES) uses a quasi-experimental design with three convenience samples: 1) a convenience sample of solid organ transplant (Tx)-recipients participating in the Transplantoux exercise training intervention, 2) matched control sample of Tx-recipients not participating in the Transplantoux exercise intervention, and 3) and a convenience sample of healthy controls participating in the Transplantoux exercise intervention. Selected PROs will be assessed using validated self-reported questionnaire. Data collection will be performed at baseline, 3 months (in the middle of the training intervention), 6 months (immediately following the intervention), 9 months (3 months follow-up period) and 12 months (6 months follow-up period).

Enrollment

500 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

  1. Tx exercise group:

    Inclusion Criteria:

    • Tx recipient (heart, lung, liver, kidney, pancreas or small bowel)
    • Age between 18 - 70 years
    • More than 1y post-transplant

    Exclusion Criteria:

    • Rejection last 6 months
    • Severe co-morbidity
    • Contra-indication for severe exercise (e.g. cardiovascular disease)
    • Insufficient knowledge of Dutch language
  2. Tx matched control group

    Inclusion Criteria:

    • Tx recipient (heart, lung, liver, kidney, pancreas or small bowel)
    • Age between 18 - 70 years
    • More than 1y post-transplant

    Exclusion Criteria:

    • Rejection last 6 months
    • Insufficient knowledge of Dutch language
  3. Healthy exercise group:

Inclusion Criteria:

  • Age between 18 - 70 years

Exclusion Criteria:

  • Contra-indication for severe exercise
  • Insufficient knowledge of Dutch language

Trial design

Primary purpose

Other

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

500 participants in 3 patient groups

Tx exercise group
Experimental group
Description:
Convenience sample of solid organ transplant recipients (heart, kidney, lung, liver, pancreas, small bowel) participating in the Transplantoux exercise training intervention. Intervention: * Home-based individualized exercise training program * Supervised group training sessions * Climb of the Mont Ventoux
Treatment:
Other: Climb of the Mont Ventoux
Other: Supervised group training sessions
Other: Home-based indiviualized exercise training program
Tx matched control group
No Intervention group
Description:
Controls are retrieved from the Leuven University Hospital heart, kidney, lung, liver, pancreas, small bowel transplant database and matched (1:4 matching) based on type of transplant, gender, age and time since transplant.
Healthy exercise group
Experimental group
Description:
Convenience sample of health care providers (e.g. doctor, paramedic or medical companion involved in care programs for organ Tx) and patient's family members and friends participating in the Transplantoux exercise training intervention. Intervention: * Supervised group training sessions * Climb of the mont ventoux
Treatment:
Other: Climb of the Mont Ventoux
Other: Supervised group training sessions

Trial contacts and locations

1

Loading...

Central trial contact

Evi Masschelein, PhD; Ceulemans

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems